CV

Monroe® Announces Expanded Parts Coverage for LCVs, SUVs and Passenger Cars

Retrieved on: 
Wednesday, November 17, 2021
Van, Ford Motor Company, Subaru Legacy, Jeep, TEN, International Transtar, Cherokee, Jetta, Technology, Noise, Toyota, Ford Transit, Strut, Clark Monroe's Uptown House, NYSE, Volkswagen, CVS, Transtar, Solution, Vibration, OE, Volkswagen Jetta, Twitter, Nissan, LCV, Murano, Kia, Sport utility vehicle, Instagram, Difference, AWD, Pathfinder, Hyundai, Air pollution, Yaris, CV, CUV, Mazda, YouTube, Tenneco, Rail transport, Motor vehicle

SOUTHFIELD, Mich., Nov. 17, 2021 /PRNewswire/ -- Monroe Shocks and Struts recently introduced new part numbers to offer expanded coverage to more than eight million vehicles in operation (VIO).

Key Points: 
  • SOUTHFIELD, Mich., Nov. 17, 2021 /PRNewswire/ -- Monroe Shocks and Struts recently introduced new part numbers to offer expanded coverage to more than eight million vehicles in operation (VIO).
  • These offerings include coverage for light commercial fleet vehicles, trucks, SUVs and CUVs, and commercial vehicles (CVs).
  • Seven new part numbers for Monroe OESpectrum shocks and struts are now offered for over 1.4 million VIO, across both domestic and import applications.
  • To learn more about Monroe ride control products, visit www.monroe.com or contact a Monroe supplier.

SeAH Besteel and Everguard.ai Embark on Major Expansion Using Novel Worker-Centric AI™ to Improve Safety

Retrieved on: 
Tuesday, November 16, 2021
Compliance, Safety, Efficiency, Computer, Seah, Ecosystem, Culture, Accident, Movement, CEO, PPE, Technology, Personal protective equipment, Artificial intelligence, Multimedia, Workforce, SOS, Atmosphere, AI, Human, RTLS, Workplace, Injury, CV, Warehouse, Risk management

Combining computer vision (CV) technology, sensor fusion, edge computing, and wearables, Sentri360 is the first truly proactive solution to industrial safety.

Key Points: 
  • Combining computer vision (CV) technology, sensor fusion, edge computing, and wearables, Sentri360 is the first truly proactive solution to industrial safety.
  • In early 2020, SeAH Besteel began an initial trial of the Sentri360 ecosystem, deploying targeted Sensor Fusion Safety Zones within the facility in areas of highest safety concern.
  • SeAH Besteel produces special steel that makes up the core components of automotive, shipbuilding, industrial machinery, construction industries and energy.
  • Everguard's mission is to protect companies' most important assets their people with the first truly proactive solution dedicated to industrial safety.

H1 Raises $100M Series C to Expand Footprint, Make H1 the Central Healthcare Professional Data Network for Global Healthcare Community

Retrieved on: 
Tuesday, November 16, 2021
Universe, Health care, Industry, Emerge Commerce, IVP, Organization, Lux Capital, CEO, Appetite, Growth, Exploration, Menlo Ventures, Academic health science centre, Hospital, GLOBE, HCPS, ARR, Goldman Sachs, Independent Healthcare Providers Network, Patient, FDA, CV, Pharmaceutical industry

H1 has built the premier healthcare data network for Healthcare Providers (HCPs), searching scholarly data and medical claims data to surface the most relevant researchers or clinicians given any criteria.

Key Points: 
  • H1 has built the premier healthcare data network for Healthcare Providers (HCPs), searching scholarly data and medical claims data to surface the most relevant researchers or clinicians given any criteria.
  • Most recently, H1s focus on allowing doctors to enhance their own individual profiles has further increased the depth and value of the proprietary data.
  • No other company can match the volume and quality of global healthcare data H1 has, and as a result no one can match the insights we surface.
  • As the trusted source of information on healthcare professionals and institutions, H1 connects the entire healthcare ecosystem through real-time data and clinical findings.

Striveworks Announces Appointment of Former FBI Executive Jay Tabb to Executive Vice President Position

Retrieved on: 
Tuesday, November 16, 2021
Intelligence, Natural language, Natural language processing, Deloitte, Government, Security Commission, National Security Commission on Artificial Intelligence, Machine learning, MLOps, National, FBI National Security Branch, Global, AI, FBI, Risk management, Solution, NLP, Computer vision, Security, Executive, CV, Management

AUSTIN, Texas, Nov. 16, 2021 /PRNewswire/ --Striveworks, Inc.,an MLOps firm for highly regulated industries, is pleased to announce the appointment of Jay Tabb as Executive Vice President of Security and Analytics.

Key Points: 
  • AUSTIN, Texas, Nov. 16, 2021 /PRNewswire/ --Striveworks, Inc.,an MLOps firm for highly regulated industries, is pleased to announce the appointment of Jay Tabb as Executive Vice President of Security and Analytics.
  • "We're incredibly excited to welcome Jay to the team here at Striveworks," said Striveworks CEO Jim Rebesco.
  • Prior to joining Striveworks, Mr. Tabb was a Senior Vice President of the Global Security Division at Crisis Response Company, where he provided domestic and international security solutions for government and commercial clients.
  • In his role at Striveworks, Mr. Tabb will be working closely with customers on bespoke AI/MLOps solutions and introducing them to Chariot, Striveworks' proprietary MLOps platform.

ElectrifAi Announces Computer Vision and MLaaS for Oil, Gas and Energy at ADIPEC

Retrieved on: 
Monday, November 15, 2021
Efficiency, Safety, Industry, Data, Accident, Organization, Heart, CEO, Failure, Insurance, Machine learning, Artificial intelligence, Multimedia, Oil, ML, Loss Time Life, Environment, Solution, Data science, Computer vision, Collection, Gas, Injury, ROI, Library, Globe, Risk, CV, Booth, Medical device, Risk management, Management

JERSEY CITY, N.J., Nov. 14, 2021 /PRNewswire/ -- ElectrifAi, one of the world's leading companies in practical artificial intelligence (Ai) and pre-built machine learning (ML) models, today announced availability of Computer Vision (CV) and Machine Learning as a Service (MLaaS) for the Oil, Gas and Energy industries at ADIPEC in Abu Dhabi. ElectrifAi will be exhibiting at Booth 13605.

Key Points: 
  • JERSEY CITY, N.J., Nov. 14, 2021 /PRNewswire/ --ElectrifAi, one of the world's leading companies in practical artificial intelligence (Ai) and pre-built machine learning (ML) models, today announcedavailability of Computer Vision (CV) and Machine Learning as a Service (MLaaS) for the Oil, Gas and Energy industries at ADIPEC in Abu Dhabi.
  • Oil, Gas and Energy companies generate extraordinary amounts of data across the enterprise.
  • And now with our innovative MLaaS offering, ElectrifAi enables companies to quickly realize the benefits of Ai and ML.
  • "We're pleased to introduce our Computer Vision and Machine Learning as a Service offerings to the global energy industry.

ElectrifAi Announces Computer Vision and MLaaS for Oil, Gas and Energy at ADIPEC

Retrieved on: 
Monday, November 15, 2021
Efficiency, Safety, Industry, Data, Accident, Organization, Heart, CEO, Failure, Insurance, Machine learning, Artificial intelligence, Oil, ML, Loss Time Life, Environment, Solution, Data science, Computer vision, Collection, Gas, Injury, ROI, Library, Globe, Risk, CV, Booth, Medical device, Risk management, Management

JERSEY CITY, N.J., Nov. 15, 2021 /PRNewswire/ -- ElectrifAi, one of the world's leading companies in practical artificial intelligence (Ai) and pre-built machine learning (ML) models, today announced availability of Computer Vision (CV) and Machine Learning as a Service (MLaaS) for the Oil, Gas and Energy industries at ADIPEC in Abu Dhabi. ElectrifAi will be exhibiting at Booth 13605.

Key Points: 
  • JERSEY CITY, N.J., Nov. 15, 2021 /PRNewswire/ --ElectrifAi, one of the world's leading companies in practical artificial intelligence (Ai) and pre-built machine learning (ML) models, today announcedavailability of Computer Vision (CV) and Machine Learning as a Service (MLaaS) for the Oil, Gas and Energy industries at ADIPEC in Abu Dhabi.
  • Oil, Gas and Energy companies generate extraordinary amounts of data across the enterprise.
  • And now with our innovative MLaaS offering, ElectrifAi enables companies to quickly realize the benefits of Ai and ML.
  • "We're pleased to introduce our Computer Vision and Machine Learning as a Service offerings to the global energy industry.

Bayer Presents New Subgroup Analysis of Prespecified Pooled Analysis of Phase III Studies for KERENDIA® (finerenone) for Chronic Kidney Disease Associated With Type 2 Diabetes With or Without SGLT2i Use at Baseline

Retrieved on: 
Monday, November 8, 2021
Health, Diabetes, Other Health, General Health, Clinical Trials, Pharmaceutical, Cardiology, Society, Phase, Failure, SOC, American Society of Nephrology, Hyperkalemia, Myocardial infarction, CKD, Type 2 diabetes, Kidney, Heart, Glomerular filtration rate, MRA, Diabetic retinopathy, Time-invariant system, Disease, EGFR, Safety, Progression, Bayer, Standard of care, Research, Trial of the century, Chronic kidney disease, ARB, Acei, C1-inhibitor, Hospital, Kidney disease, Incidence, Patient, NYHA, Heart failure, Finerenone, Chemistry (relationship), T2D, ASN, Risk, CV, Kidney failure, Mortality, Adult, Pharmaceutical industry, Dietary supplement, Finerenone Phase III Clinical Trials Program, KERENDIA (finerenone), Chronic Kidney Disease Associated With Type 2 Diabetes, Bayer’s Commitment in Cardiovascular and Kidney Diseases, Bayer, FINERENONE PHASE III CLINICAL TRIALS PROGRAM, KERENDIA (FINERENONE), CHRONIC KIDNEY DISEASE ASSOCIATED WITH TYPE 2 DIABETES, BAYER’S COMMITMENT IN CARDIOVASCULAR AND KIDNEY DISEASES, BAYER

Measure serum potassium and eGFR in all patients before initiation of treatment with KERENDIA and dose accordingly.

Key Points: 
  • Measure serum potassium and eGFR in all patients before initiation of treatment with KERENDIA and dose accordingly.
  • Do not initiate KERENDIA if serum potassium is >5.0 mEq/L4
    Measure serum potassium periodically during treatment with KERENDIA and adjust dose accordingly.
  • 2017;12(12):2032-2045. doi:10.2215/CJN.11491116
    Anders HJ, Huber TB, Isermann B, Schiffer M. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease.
  • Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging.

Cardiovascular Systems, Inc. Announces First In-Human Experience With Coronary Everolimus Drug Coated Balloon

Retrieved on: 
Thursday, November 4, 2021
Health, Medical Devices, Cardiology, Cytostasis, Calcium, Clinical trial, Artery, Plaque, Leg, ISR, Peripheral artery disease, Annual report, Acquisition, CSI, Coronary artery disease, Risk, CV, Form 10-Q, Moyamoya disease, Safety, COO, Form 10-K, CAD, Testosterone and the cardiovascular system, Medtronic, DCB Bank, PCI, Woman, Everolimus, Medical Affairs Bureau, Patient, FDA, View, Private Securities Litigation Reform Act, Organization, Heart, Degenerative disease, NASDAQ, Doctor of Philosophy, Cardiovascular disease, LLC, Twitter, SEC, Man, Atherosclerosis, Stent, Korea Disease Control and Prevention Agency, News, IDE, DCB, MACE, Hospital, Center, Death, Physician, Diabetes, Pharmaceutical industry, Medical imaging, Cardiovascular Systems, Inc., Chansu Vascular Technologies, LLC, Coronary Artery Disease (CAD), CARDIOVASCULAR SYSTEMS, INC., CHANSU VASCULAR TECHNOLOGIES, LLC, CORONARY ARTERY DISEASE (CAD)

Everolimus, the active drug in CVTs DCB formulation, acts as a cytostatic agent to reduce tissue hyperplasia and associated restenosis and has a long history of safety and efficacy in coronary drug-eluting stent applications.

Key Points: 
  • Everolimus, the active drug in CVTs DCB formulation, acts as a cytostatic agent to reduce tissue hyperplasia and associated restenosis and has a long history of safety and efficacy in coronary drug-eluting stent applications.
  • Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease.
  • CVT was founded by Philippe Marco, MD, with the exclusive purpose to develop peripheral and coronary DCBs using everolimus.
  • CSI is a registered trademark of Cardiovascular Systems, Inc. All other trademarks cited herein are owned by their respective owners.

Forrester Research Reports 2021 Third-Quarter Financial Results

Retrieved on: 
Wednesday, November 3, 2021
EPS, Research, CV, Compliance, Technology, Industry, Failure, GAAP, European Union, Forrester Research, Security (finance), U.S. Securities and Exchange Commission, Private Securities Litigation Reform Act, Overalls, FORR, Leadership, Forrester, Income, Marketing, United Kingdom, Investment, Growth, COVID-19, Privacy, Union, Nasdaq, Acquisition, Ownership, Airline, Music, Video game, Risk management

CAMBRIDGE, Mass., Nov. 3, 2021 /PRNewswire/ --Forrester Research, Inc. (Nasdaq: FORR) today announced its 2021 third-quarter financial results.

Key Points: 
  • CAMBRIDGE, Mass., Nov. 3, 2021 /PRNewswire/ --Forrester Research, Inc. (Nasdaq: FORR) today announced its 2021 third-quarter financial results.
  • As part of the company's pivot to contract value (CV) in 2021, Forrester is classifying all components of its CV subscription research products as research revenues.
  • Forrester is providing fourth-quarter and full-year 2021 financial guidance as follows:
    Total revenues of approximately $131.0 million to $136.0 million.
  • These statements include, but are not limited to, Forrester's financial guidance for the fourth quarter of and full-year 2021 and statements about the launch and performance of Forrester Decisions and Forrester's future financial performance and financial condition.

Smart Electric Drive Market worth $4,245 million by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, November 2, 2021
Knowledge, Geely, Nidec, ZF, CATL, CV, Technology, Research, Denso, Tesla, GEM, CHAdeMO, RWD, Electricity, FCEV, AWD, BMW, BYD, Adoption, Aisin, Original equipment manufacturer, Tesla Supercharger, EVS, SME, Samsung, Intelligence, PHEV, GAC, Component, Fast, Type 2 connector, SK Group, Growth, BEV, BorgWarner, DC, Traction, LG Chem, D, Volvo, FWD, Panasonic, CCS, Rest, GKN, Rail transport, Marketing

The Asia Pacific Smart Electric Drive Market will be led by countries like China, Japan and South Korea.

Key Points: 
  • The Asia Pacific Smart Electric Drive Market will be led by countries like China, Japan and South Korea.
  • This will lead to a fast-growing demand for the Smart Electric Drive Market in the region with their increased adoption in EV's and rising EV demand.
  • With the rise in production capacity/ mass manufacturing for smart drivetrain and adoption of technology by OEMs in a country would support growth of Smart Electric Drive Market.
  • Thus, with component manufacturers and OEMs adopting advanced integrated technologies to provide smart electric drive, the market would grow in the near future.